-
Curtiss-Wright expands 2026 share buyback by $100M to $260M total
New $100M 10b5-1 plan effective Aug 18, 2026; purchases cease by end of August 2026.
-
Curtiss-Wright Q2 adj EPS $3.72 beats; raises FY2026 guidance on strong orders
Q2 sales $924M (+5% YoY); adj operating margin 19.4% (+110 bps); adj diluted EPS $3.72 (+15%).
-
Curtiss-Wright Q1 sales $914M (+13%), EPS $3.46; raises FY2026 guidance
Q1 sales $914M (+13% YoY), adjusted op margin 17.6% (+100bps), adjusted diluted EPS $3.48 (+23%).
-
Curtiss-Wright Q4 adj. EPS $3.79 (+16%), FY25 record sales $3.5B; FY26 EPS view $14.70-$15.15
Q4 sales $947M (+15%), adj. operating margin 19.7%, diluted EPS $3.69 (GAAP), adj. diluted EPS $3.79 (+16%).
-
Curtiss-Wright increases buyback authorization to $550M, declares $0.24 dividend
Board authorized additional $416M for share repurchases; total authorization now $550M.
-
Curtiss-Wright Q3 sales +9%, adj. EPS $3.40 +14%; raises FY2025 outlook
Q3 sales $869M (+9% YoY); adj. op. income $170M (+14%); adj. diluted EPS $3.40 (+14%).
-
Curtiss-Wright expands share repurchase by $200M, declares $0.24 quarterly dividend
Company adopts 10b5-1 plan to repurchase additional $200M, targeting record annual repurchases >$450M in 2025.
-
Curtiss-Wright expands 2025 share repurchase program by $200M, total now $266M
Adopted 10b5-1 trading plan to repurchase $200M of common stock; effective Aug 11, 2025, expected completion by end of August.
-
Curtiss-Wright Q2 2025: Sales up 12% to $877M; raises FY2025 guidance
Q2 reported sales $877M (+12% YoY), operating income $156M (+21%), diluted EPS $3.19 (+24%).
-
Curtiss-Wright Q1 EPS $2.68 beats; raises FY25 guidance (sales +8-9%, EPS $12.45-12.80)
Q1 sales $806M (+13% YoY); diluted EPS $2.68 (+35%); adjusted EPS $2.82 (+42%).
-
Curtiss-Wright reports record FY2024 sales of $3.1B, issues 2025 guidance for double-digit EPS growth
Q4 sales $824M (+5%), adj. EPS $3.27 (+3%); FY sales $3.1B (+10%), adj. EPS $10.90 (+16%).
-
Curtiss-Wright expands 2024 share repurchase by $100M, raises 2025 annual plan to $60M
New $100M 10b5-1 share repurchase program to be executed by Dec 31, 2024, bringing total 2024 buybacks to $250M.
-
Curtiss-Wright Q3 sales $799M (+10%), adj EPS $2.97 (+17%); raises FY guidance
Sales $799M (+10%), adj operating income $149M (+11%), adj operating margin 18.7% (+20 bps).
-
Curtiss-Wright Q2 adj. EPS $2.67 (+24% YoY); raises full-year 2024 guidance
Q2 sales $785M (+11% YoY); adj. op. margin 17.0% (+60 bps); adj. diluted EPS $2.67 (+24%).
-
Curtiss-Wright introduces 3-year targets: >5% organic revenue CAGR, >10% EPS CAGR
Organic revenue CAGR of at least 5% over 2024-2026, with EPS CAGR exceeding 10%.
-
Curtiss-Wright boosts buyback authorization by $300M and raises dividend 5% to $0.21
Board authorized $300M share repurchase increase, total available authorization now $400M.
-
Curtiss-Wright Q1 sales up 13% to $713M, EPS $1.99; raises full-year guidance
Q1 sales $713M (+13% YoY), operating income $100M (+27%), diluted EPS $1.99 (+30%).
-
Curtiss-Wright reports record FY23 sales $2.8B, adj EPS $9.38; guides FY24 EPS $10-10.30
Q4 adj diluted EPS $3.16 (+8% YoY); Q4 sales $786M (+4%) on 3% organic growth.
-
Curtiss-Wright Q3 sales +15%, adj EPS $2.54 (+23%); raises FY23 guidance
Reported sales $724M (+15% YoY); adj operating income $134M (+17%); adj diluted EPS $2.54 vs $2.07 last year.
-
Curtiss-Wright Q2 adjusted EPS $2.15 (+18%); raises FY2023 EPS guidance to $8.90-$9.15
Q2 adjusted diluted EPS $2.15 (+18% YoY); sales $704M (+16%).
-
Curtiss-Wright Q1 sales up 13% to $631M, adj. EPS $1.53 (+17%), reaffirms 2023 guidance
Reported sales $631M (+13% YoY); adj. operating income $81M (+15%); adj. diluted EPS $1.53 (+17%).
-
Curtiss-Wright Q4 adj. EPS $2.92 (+21% YoY); FY23 guidance: sales +4-6%, EPS $8.65-8.90
Q4 adjusted sales $758M (+16% YoY); adjusted operating margin 21.1% (+140 bps).
-
Curtiss-Wright adopts two 10b5-1 plans for $150M share repurchases in 2023
Board authorized $550M buyback on Sept 16, 2021; $350M already used through 2022.
-
Curtiss-Wright Q3 adjusted EPS $2.07 (+10%), cuts FY sales growth to 2-4% amid supply chain delays
Q3 adjusted sales $631M (+3%), adjusted operating income $114M (+6%), adjusted EPS $2.07 (+10%).
-
Curtiss-Wright Q2 adj. EPS $1.83 (+18%), raises FY2022 guidance, prices $300M senior notes
Adjusted diluted EPS $1.83, up 18% YoY; reported EPS $1.83 vs $1.49.
-
Curtiss-Wright enters new $750M revolving credit facility, replacing $500M prior facility
New $750M revolving credit facility replaces prior $500M facility; accordion feature expanded to $250M.
-
Curtiss-Wright Q1 adj EPS $1.31 beats expectations; sales $559M down 5%; reaffirms FY2022 guidance
Reported EPS $1.05, adjusted EPS $1.31; revenue $559M, down 5% adjusted YoY.
-
Curtiss-Wright resolves proxy contest; Saddle Point withdraws nominees and proposals
Saddle Point Management withdrew its shareholder proposals and director nominees for the 2022 Annual Meeting.
-
Curtiss-Wright files preliminary proxy; discloses Saddle Point nominations for board seats
Saddle Point Management (0.298% stake) nominated four directors; company urges withdrawal and constructive dialogue.
-
Curtiss-Wright Q4 adj. EPS $2.40 up 6% YoY; FY2022 EPS guidance $8.05-$8.25 (+10-12%)
Q4 2021 adjusted sales $655M (+2%), adjusted operating margin 19.7% flat, adjusted diluted EPS $2.40 (+6%).
-
Curtiss-Wright Q3 adj EPS $1.88 (+6%); raises FY21 EPS guidance, adds $400M buyback
Adj diluted EPS $1.88, up 6% YoY; reported EPS $1.70. Adj sales $614M, up 12%.
-
Curtiss-Wright adopts 10b5-1 trading plan for $200M share repurchase under $550M program
Board authorized $550M share repurchase program, announced Sep 16, 2021.
-
Curtiss-Wright Q2 adjusted EPS $1.56, up 22% YoY; raises full-year guidance
Adjusted sales $609M (+14% YoY); adjusted operating margin 15.6%, up 120 bps.